Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles

Abstract The HIV-1 envelope glycoprotein trimer is poorly immunogenic because it is covered by a dense glycan shield. As a result, recombinant Env glycoproteins generally elicit inadequate antibody levels that neutralize clinically relevant, neutralization-resistant (Tier-2) HIV-1 strains. Multivale...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Philip J. M. Brouwer, Aleksandar Antanasijevic, Marlon de Gast, Joel D. Allen, Tom P. L. Bijl, Anila Yasmeen, Rashmi Ravichandran, Judith A. Burger, Gabriel Ozorowski, Jonathan L. Torres, Celia LaBranche, David C. Montefiori, Rajesh P. Ringe, Marit J. van Gils, John P. Moore, Per Johan Klasse, Max Crispin, Neil P. King, Andrew B. Ward, Rogier W. Sanders
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/6d2ce266cff0455eb80fcc32049d700d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6d2ce266cff0455eb80fcc32049d700d
record_format dspace
spelling oai:doaj.org-article:6d2ce266cff0455eb80fcc32049d700d2021-12-02T14:26:46ZImmunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles10.1038/s41541-021-00285-92059-0105https://doaj.org/article/6d2ce266cff0455eb80fcc32049d700d2021-02-01T00:00:00Zhttps://doi.org/10.1038/s41541-021-00285-9https://doaj.org/toc/2059-0105Abstract The HIV-1 envelope glycoprotein trimer is poorly immunogenic because it is covered by a dense glycan shield. As a result, recombinant Env glycoproteins generally elicit inadequate antibody levels that neutralize clinically relevant, neutralization-resistant (Tier-2) HIV-1 strains. Multivalent antigen presentation on nanoparticles is an established strategy to increase vaccine-driven immune responses. However, due to nanoparticle instability in vivo, the display of non-native Env structures, and the inaccessibility of many neutralizing antibody (NAb) epitopes, the effects of nanoparticle display are generally modest for Env trimers. Here, we generate two-component self-assembling protein nanoparticles presenting twenty SOSIP trimers of the clade C Tier-2 genotype 16055. We show in a rabbit immunization study that these nanoparticles induce 60-fold higher autologous Tier-2 NAb titers than the corresponding SOSIP trimers. Epitope mapping studies reveal that the presentation of 16055 SOSIP trimers on these nanoparticle focuses antibody responses to an immunodominant apical epitope. Thus, these nanoparticles are a promising platform to improve the immunogenicity of Env trimers with apex-proximate NAb epitopes.Philip J. M. BrouwerAleksandar AntanasijevicMarlon de GastJoel D. AllenTom P. L. BijlAnila YasmeenRashmi RavichandranJudith A. BurgerGabriel OzorowskiJonathan L. TorresCelia LaBrancheDavid C. MontefioriRajesh P. RingeMarit J. van GilsJohn P. MoorePer Johan KlasseMax CrispinNeil P. KingAndrew B. WardRogier W. SandersNature PortfolioarticleImmunologic diseases. AllergyRC581-607Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Vaccines, Vol 6, Iss 1, Pp 1-14 (2021)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Immunologic diseases. Allergy
RC581-607
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Philip J. M. Brouwer
Aleksandar Antanasijevic
Marlon de Gast
Joel D. Allen
Tom P. L. Bijl
Anila Yasmeen
Rashmi Ravichandran
Judith A. Burger
Gabriel Ozorowski
Jonathan L. Torres
Celia LaBranche
David C. Montefiori
Rajesh P. Ringe
Marit J. van Gils
John P. Moore
Per Johan Klasse
Max Crispin
Neil P. King
Andrew B. Ward
Rogier W. Sanders
Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles
description Abstract The HIV-1 envelope glycoprotein trimer is poorly immunogenic because it is covered by a dense glycan shield. As a result, recombinant Env glycoproteins generally elicit inadequate antibody levels that neutralize clinically relevant, neutralization-resistant (Tier-2) HIV-1 strains. Multivalent antigen presentation on nanoparticles is an established strategy to increase vaccine-driven immune responses. However, due to nanoparticle instability in vivo, the display of non-native Env structures, and the inaccessibility of many neutralizing antibody (NAb) epitopes, the effects of nanoparticle display are generally modest for Env trimers. Here, we generate two-component self-assembling protein nanoparticles presenting twenty SOSIP trimers of the clade C Tier-2 genotype 16055. We show in a rabbit immunization study that these nanoparticles induce 60-fold higher autologous Tier-2 NAb titers than the corresponding SOSIP trimers. Epitope mapping studies reveal that the presentation of 16055 SOSIP trimers on these nanoparticle focuses antibody responses to an immunodominant apical epitope. Thus, these nanoparticles are a promising platform to improve the immunogenicity of Env trimers with apex-proximate NAb epitopes.
format article
author Philip J. M. Brouwer
Aleksandar Antanasijevic
Marlon de Gast
Joel D. Allen
Tom P. L. Bijl
Anila Yasmeen
Rashmi Ravichandran
Judith A. Burger
Gabriel Ozorowski
Jonathan L. Torres
Celia LaBranche
David C. Montefiori
Rajesh P. Ringe
Marit J. van Gils
John P. Moore
Per Johan Klasse
Max Crispin
Neil P. King
Andrew B. Ward
Rogier W. Sanders
author_facet Philip J. M. Brouwer
Aleksandar Antanasijevic
Marlon de Gast
Joel D. Allen
Tom P. L. Bijl
Anila Yasmeen
Rashmi Ravichandran
Judith A. Burger
Gabriel Ozorowski
Jonathan L. Torres
Celia LaBranche
David C. Montefiori
Rajesh P. Ringe
Marit J. van Gils
John P. Moore
Per Johan Klasse
Max Crispin
Neil P. King
Andrew B. Ward
Rogier W. Sanders
author_sort Philip J. M. Brouwer
title Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles
title_short Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles
title_full Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles
title_fullStr Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles
title_full_unstemmed Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles
title_sort immunofocusing and enhancing autologous tier-2 hiv-1 neutralization by displaying env trimers on two-component protein nanoparticles
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/6d2ce266cff0455eb80fcc32049d700d
work_keys_str_mv AT philipjmbrouwer immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT aleksandarantanasijevic immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT marlondegast immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT joeldallen immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT tomplbijl immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT anilayasmeen immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT rashmiravichandran immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT judithaburger immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT gabrielozorowski immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT jonathanltorres immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT celialabranche immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT davidcmontefiori immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT rajeshpringe immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT maritjvangils immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT johnpmoore immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT perjohanklasse immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT maxcrispin immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT neilpking immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT andrewbward immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT rogierwsanders immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
_version_ 1718391315987693568